Skip to content
10-Q

Quarterly Report

IO Biotech, Inc. IOBTQ

0000950170-25-070956

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 65.88M sh
Shares Diluted Q1 2025 · Mar 31, 2025 65.88M sh
Shares Diluted Q1 2025 · Mar 31, 2024 65.88M sh
Capex Q1 2025 · Mar 31, 2025 $28K
Capex Q1 2025 · Mar 31, 2024 $11K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$23.07M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$24.93M
Long Term Debt Q1 2025 · Mar 31, 2025 $0
Short Term Debt Q1 2025 · Mar 31, 2025 $0
Cash And Equivalents Q1 2025 · Mar 31, 2025 $37.09M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $60.03M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $117.98M
Stockholders Equity Q1 2025 · Mar 31, 2025 $26.42M
Stockholders Equity Q1 2025 · Dec 31, 2024 $47.02M
Stockholders Equity Q1 2025 · Mar 31, 2024 $115.47M
Stockholders Equity Q1 2025 · Dec 31, 2023 $133.16M
Current Liabilities Q1 2025 · Mar 31, 2025 $18.29M
Current Liabilities Q1 2025 · Dec 31, 2024 $19.49M
Total Liabilities Q1 2025 · Mar 31, 2025 $19.31M
Total Liabilities Q1 2025 · Dec 31, 2024 $20.68M
Current Assets Q1 2025 · Mar 31, 2025 $42.34M
Current Assets Q1 2025 · Dec 31, 2024 $64.95M
Total Assets Q1 2025 · Mar 31, 2025 $45.74M
Total Assets Q1 2025 · Dec 31, 2024 $67.7M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.34
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.30
Eps Basic Q1 2025 · Mar 31, 2025 −$0.34
Eps Basic Q1 2025 · Mar 31, 2024 −$0.30
Sga Expense Q1 2025 · Mar 31, 2025 $6.21M
Sga Expense Q1 2025 · Mar 31, 2024 $5.89M
Rd Expense Q1 2025 · Mar 31, 2025 $16.38M
Rd Expense Q1 2025 · Mar 31, 2024 $14.31M
Net Income Q1 2025 · Mar 31, 2025 −$22.42M
Net Income Q1 2025 · Dec 31, 2024 −$95.5M
Net Income Q1 2025 · Mar 31, 2024 −$19.46M
Operating Income Q1 2025 · Mar 31, 2025 −$22.58M
Operating Income Q1 2025 · Mar 31, 2024 −$20.2M